LabCentral and Pfizer plans to open LabCentral 610, a new lab offering located at Pfizer’s Kendall Square Worldwide R&D campus. The 33,000-sq.-ft. facility is scheduled to open in December and will house as many as six early- to mid-stage companies. Eligible startups include those with high-impact science and and significant prospects for achieving scientific and business success whose space needs exceed current LabCentral offerings. The companies may be ‘graduates’ from the current LabCentr...